Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.

 
Web www.patentalert.com

< Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences

< Active Ingredient Compositions for Plant Protection

> Methods for determining whether a chemical agent modulates enzymatic activity of an L-2-hydroxy acid oxidase

> Methods of treating fibrosing diseases by induction of immune tolerance

~ 00607